FR2847267B1 - Procede de test de l'activite d'une substance potentiellement active pour inhiber l'activite enzymatique de la phospholipase a2 - Google Patents
Procede de test de l'activite d'une substance potentiellement active pour inhiber l'activite enzymatique de la phospholipase a2Info
- Publication number
- FR2847267B1 FR2847267B1 FR0214490A FR0214490A FR2847267B1 FR 2847267 B1 FR2847267 B1 FR 2847267B1 FR 0214490 A FR0214490 A FR 0214490A FR 0214490 A FR0214490 A FR 0214490A FR 2847267 B1 FR2847267 B1 FR 2847267B1
- Authority
- FR
- France
- Prior art keywords
- activity
- phospholipase
- inhibiting
- testing
- active substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
- G01N2333/918—Carboxylic ester hydrolases (3.1.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0214490A FR2847267B1 (fr) | 2002-11-19 | 2002-11-19 | Procede de test de l'activite d'une substance potentiellement active pour inhiber l'activite enzymatique de la phospholipase a2 |
US10/365,897 US20040096925A1 (en) | 2002-11-19 | 2003-02-12 | Method of testing the activity of a potentially active substance to inhibit the enzymatic activity of phospholipase A2 |
CH00269/03A CH694107A5 (fr) | 2002-11-19 | 2003-02-20 | Procédé de test pour la recherche et l'identification d'une substance potentiellement active pour inhiber l'activité enzymatique de la phospholipase A2 |
JP2003048891A JP2004166684A (ja) | 2002-11-19 | 2003-02-26 | ホスホリパーゼa2の酵素活性を阻害するのに有効である可能性がある物質の活性の試験方法 |
KR20030017869A KR101172700B1 (ko) | 2002-11-19 | 2003-03-21 | 포스포리파아제 a2의 효소활성을 억제하기 위한 잠재적활성물질의 활성 검사방법 |
DE2003120603 DE10320603A1 (de) | 2002-11-19 | 2003-05-08 | Verfahren zum Testen der Aktivität einer möglichen wirksamen Substanz, die die enzymatische Aktivität der Phospholipase A2 hemmen kann |
DE10362194.6A DE10362194C5 (de) | 2002-11-19 | 2003-05-08 | Verfahren zum Testen der Aktivität einer möglichen wirksamen Substanz, die die enzymatische Aktivität der Phospholipase A2 hemmen kann |
JP2009032657A JP5425489B2 (ja) | 2002-11-19 | 2009-02-16 | ホスホリパーゼa2の酵素活性を阻害するのに有効である可能性がある物質の活性の試験方法 |
JP2012168187A JP2012224637A (ja) | 2002-11-19 | 2012-07-30 | ホスホリパーゼa2の酵素活性を阻害するのに有効である可能性がある物質の活性の試験方法 |
US14/585,256 US20150110907A1 (en) | 2002-11-19 | 2014-12-30 | Method of testing the activity of a potentially active substance to inhibit the enzymatic activity of phospholipase a2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0214490A FR2847267B1 (fr) | 2002-11-19 | 2002-11-19 | Procede de test de l'activite d'une substance potentiellement active pour inhiber l'activite enzymatique de la phospholipase a2 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2847267A1 FR2847267A1 (fr) | 2004-05-21 |
FR2847267B1 true FR2847267B1 (fr) | 2006-07-28 |
Family
ID=32187745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0214490A Expired - Lifetime FR2847267B1 (fr) | 2002-11-19 | 2002-11-19 | Procede de test de l'activite d'une substance potentiellement active pour inhiber l'activite enzymatique de la phospholipase a2 |
Country Status (6)
Country | Link |
---|---|
US (2) | US20040096925A1 (fr) |
JP (3) | JP2004166684A (fr) |
KR (1) | KR101172700B1 (fr) |
CH (1) | CH694107A5 (fr) |
DE (2) | DE10320603A1 (fr) |
FR (1) | FR2847267B1 (fr) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005019653A1 (de) * | 2005-04-26 | 2006-11-02 | Henkel Kgaa | Pflanzenextrakte gegen Halitosis, Gingivitis oder Parodontitis |
FR2892635B1 (fr) | 2005-10-28 | 2012-11-09 | Engelhard Lyon | Substance pour restaurer une co-expression et une interaction normales entre les proteines lox et nrage |
FR2916977A1 (fr) | 2007-06-06 | 2008-12-12 | Engelhard Lyon Sa | STIMULATION DE LA SYNTHESE DES RECPTEURS MCR1, MCR2 ET µ OPIOIDE. |
CN101686918B (zh) | 2007-06-28 | 2014-05-21 | 巴斯夫美容护理法国公司 | 减肥组合物 |
US8440237B2 (en) | 2009-04-27 | 2013-05-14 | Mary Kay Inc. | Botanical anti-acne formulations |
FR2954702B1 (fr) | 2009-12-31 | 2013-07-05 | Basf Beauty Care Solutions F | Agent stimulant l'expression de loxl |
EP3566691B1 (fr) | 2011-12-19 | 2024-04-17 | Mary Kay Inc. | Procédé cosmétique pour blanchir la peau et uniformiser le teint avec des haricot azuki |
FR2994387B1 (fr) | 2012-08-13 | 2016-07-29 | Basf Beauty Care Solutions France Sas | Ingredient hydratant cosmetique ou pharmaceutique |
FR2997406B1 (fr) | 2012-10-25 | 2015-07-03 | Basf Beauty Care Solutions F | Polymere de hyaluronate et de glucomannane |
FR3000488B1 (fr) | 2012-12-27 | 2015-10-02 | Basf Beauty Care Solutions F | Nouveaux derives de l'acide sinapique et leurs utilisations cosmetiques ou pharmaceutiques |
FR3003758B1 (fr) | 2013-03-27 | 2015-07-17 | Basf Beauty Care Solutions France Sas | Utilisation cosmetique ou dermatologique d'un extrait de polygonum bistorta |
FR3009786B1 (fr) | 2013-08-23 | 2017-08-11 | Basf Beauty Care Solutions France Sas | Utilisation cosmetique ou dermatologique d'un extrait de quassia amara |
FR3010314B1 (fr) | 2013-09-12 | 2017-05-05 | Basf Beauty Care Solutions France Sas | Utilisation cosmetique ou dermatologique d'un extrait de tapirira guyanensis |
EP3116469B1 (fr) | 2014-03-10 | 2018-10-03 | Mary Kay, Inc. | Compositions d'éclaircissement de la peau |
FR3026947B1 (fr) | 2014-10-10 | 2017-12-08 | Basf Beauty Care Solutions France Sas | Activite deglycation d'une combinaison d'un extrait de salvia miltiorrhiza et de niacine et/ou de niacinamide |
JP7032852B2 (ja) * | 2014-11-29 | 2022-03-09 | 共栄化学工業株式会社 | 毛髪化粧料 |
FR3030275B1 (fr) | 2014-12-23 | 2018-03-02 | Basf Beauty Care Solutions France Sas | Utilisation d'un extrait de lythrum salicaria |
EP3258269B1 (fr) * | 2015-02-10 | 2019-06-05 | Shenzhen New Industries Biomedical Engineering Co. Ltd. | Kit de réactifs utilisé pour la détection de la phospholipase a2 associée aux lipoprotéines, et procédé de préparation et application du kit de réactifs |
FR3049859B1 (fr) | 2016-04-12 | 2023-11-03 | Basf Beauty Care Solutions France Sas | Utilisation cosmetique d'un extrait de khaya senegalensis |
FR3058641B1 (fr) | 2016-11-17 | 2019-11-01 | Basf Beauty Care Solutions France Sas | Utilisation cosmetique, nutraceutique ou pharmaceutique preferentiellement dermatologique d'un extrait de feuilles de la plante lansium domesticum pour diminuer la pigmentation de la peau et/ou des annexes cutanees |
FR3061015B1 (fr) | 2016-12-23 | 2019-09-20 | Basf Beauty Care Solutions France Sas | Utilisation cosmetique d'un extrait de corchorus olitorius |
FR3065876B1 (fr) | 2017-05-05 | 2020-08-14 | Basf Beauty Care Solutions France Sas | Utilisation d'un extrait de nephelium lappaceum pour augmenter la fermete de la peau et/ou des muqueuses |
FR3069162A1 (fr) | 2017-07-24 | 2019-01-25 | Basf Beauty Care Solutions France Sas | Extrait aqueux de momordica cochinchinensis pour maintenir et/ou augmenter l'expression des kindlines de la peau et des muqueuses |
FR3071742B1 (fr) | 2017-10-03 | 2020-07-10 | Basf Beauty Care Solutions France Sas | Procede d'utilisation d'un inhibiteur de let-7b en cosmetique et/ou en nutraceutique |
FR3097127B1 (fr) | 2017-10-03 | 2022-09-16 | Basf Beauty Care Solutions France Sas | Procédé d’utilisation d’un inhibiteur de Let-7b en cosmétique et/ou en nutraceutique |
KR102227399B1 (ko) * | 2019-10-08 | 2021-03-15 | 이화여자대학교 산학협력단 | 내열성 신규 포스포리파아제 a2 및 포스포리파아제 a2 생산방법 |
FR3106756B1 (fr) | 2020-01-30 | 2023-12-22 | BASF Beauty Care Solutions France | Utilisation cosmétique, nutraceutique ou dermatologique d'un extrait deTamarindus indicaL. et / ou d’une composition le comprenant |
FR3110415B1 (fr) | 2020-05-20 | 2023-07-14 | Basf Beauty Care Solutions France Sas | Utilisation d’un extrait d’adansonia digitatapour maintenir et / ou diminuer la communication bacterienne |
FR3117340B1 (fr) | 2020-12-15 | 2024-01-05 | Basf Beauty Care Solutions France Sas | Utilisation cosmétique, nutraceutique ou dermatologique d’une souche deLactobacillus crispatus et / ou d’une composition la comprenant |
FR3133312A1 (fr) | 2022-03-08 | 2023-09-15 | Basf Beauty Care Solutions France Sas | Utilisation cosmétique ou dermatologique de Sphingomonas glacialis et/ou d’une composition la comprenant |
WO2023180661A1 (fr) | 2022-03-23 | 2023-09-28 | Basf Beauty Care Solutions France Sas | Utilisation cosmetique ou dermatologique d'un extrait de dendrobium officinale pour maintenir et/ou augmenter l'epaisseur de la peau |
CN116831962A (zh) | 2022-03-23 | 2023-10-03 | 巴斯夫美容护理法国公司 | 铁皮石斛提取物用于维持和/或增加皮肤厚度的化妆或皮肤病学用途 |
FR3134010A1 (fr) | 2022-03-30 | 2023-10-06 | Basf Beauty Care Solutions France Sas | Utilisation cosmétique, nutraceutique et/ou dermatologique d’une souche de Lactobacillus crispatus et/ou d’une composition la comprenant |
FR3138039A1 (fr) | 2022-07-21 | 2024-01-26 | Basf Beauty Care Solutions France Sas | Utilisation cosmétique ou dermatologique d’un extrait de Pyracantha fortuneana |
WO2024008647A1 (fr) | 2022-07-04 | 2024-01-11 | Basf Beauty Care Solutions France Sas | Utilisation cosmétique ou dermatologique d'un extrait de pyracantha fortuneana |
FR3138615A1 (fr) | 2022-08-02 | 2024-02-09 | Basf Beauty Care Solutions France Sas | Nouvelle utilisation cosmétique ou dermatologique d’un extrait de Gentiana crassicaulis |
WO2024023440A1 (fr) | 2022-07-26 | 2024-02-01 | Basf Beauty Care Solutions France Sas | Nouvelle utilisation cosmetique ou dermatologique d'un extrait de gentiana crassicaulis |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0489839B1 (fr) * | 1989-08-29 | 1996-11-27 | The Regents Of The University Of California | Nouveaux inhibiteurs d'enzymes hydrolytiques, substrats et analyses, methodes et coffrets d'analyses s'y rapportant |
US5436239A (en) * | 1992-04-01 | 1995-07-25 | The University Of Virginia Patent Foundation | Method of treating clostridium difficile colitis and cholera |
JP2691662B2 (ja) * | 1992-07-08 | 1997-12-17 | 花王株式会社 | 化粧料 |
JP2764510B2 (ja) * | 1992-12-28 | 1998-06-11 | 花王株式会社 | 美白化粧料 |
JP3529811B2 (ja) * | 1993-06-30 | 2004-05-24 | 三省製薬株式会社 | 皮膚外用剤 |
JPH0733673A (ja) * | 1993-07-19 | 1995-02-03 | Taisho Pharmaceut Co Ltd | テストステロン−5α−リダクターゼ阻害剤 |
JPH07126166A (ja) * | 1993-10-29 | 1995-05-16 | Sagami Chem Res Center | ホスホリパ−ゼa2阻害剤 |
US5888984A (en) * | 1994-05-12 | 1999-03-30 | Dermal Research Laboratories, Inc. | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
JP3696271B2 (ja) * | 1994-09-22 | 2005-09-14 | 花王株式会社 | 美白化粧料 |
JP3233813B2 (ja) * | 1995-03-31 | 2001-12-04 | 株式会社マンダム | チロシナーゼ生合成促進剤及び白髪改善用又は白髪防止用頭髪用化粧料並びに日焼け用化粧料 |
US6025178A (en) * | 1997-03-28 | 2000-02-15 | Eli Lilly And Company | Human phospholipase A2 and related nucleic acid compounds |
FR2757395B1 (fr) * | 1996-12-20 | 1999-03-12 | Dior Christian Parfums | Utilisation d'un extrait de la plante davallia, dans les domaines cosmetique et pharmaceutique, notamment dermatologique |
JP4676040B2 (ja) * | 1997-07-31 | 2011-04-27 | 株式会社林原生物化学研究所 | 組成物 |
US5952374A (en) * | 1997-09-29 | 1999-09-14 | Protein Technologies International, Inc. | Method for inhibiting the development of Alzheimer's disease and related dementias- and for preserving cognitive function |
DE29717497U1 (de) * | 1997-10-01 | 1999-02-04 | Braun Michaela Dipl Ing | Kosmetischer Tee-Extrakt |
US5904924A (en) * | 1997-11-04 | 1999-05-18 | Oncologics, Inc. | Green nutritional powder composition |
WO2000002561A1 (fr) * | 1998-07-13 | 2000-01-20 | University Of South Florida | Modulation de la voie de phospholipase a2 utilisee comme procede therapeutique |
FR2787996B1 (fr) * | 1998-12-30 | 2002-05-10 | Dior Christian Parfums | Composition cosmetique ou dermatologique contenant un actif stimulant la synthese de la proteine hsp 32 dans la peau et methode de traitement cosmetique |
JP2000247830A (ja) * | 1999-02-26 | 2000-09-12 | Nagase & Co Ltd | エラスターゼ阻害剤 |
JP2000319191A (ja) * | 1999-03-05 | 2000-11-21 | Takeda Chem Ind Ltd | サイクリックgmp特異的ホスホジエステラーゼ阻害剤および性的機能障害改善薬 |
JP2000351723A (ja) * | 1999-06-09 | 2000-12-19 | Naris Cosmetics Co Ltd | 皮膚外用剤 |
JP2001158728A (ja) * | 1999-12-01 | 2001-06-12 | Shiseido Co Ltd | ヒアルロン酸産生促進剤および皮膚外用剤 |
WO2001042462A2 (fr) * | 1999-12-08 | 2001-06-14 | National University Of Singapore | Nouveaux agents therapeutiques et prophylactiques et leurs procedes d'utilisation |
FR2802818B1 (fr) * | 1999-12-24 | 2002-08-30 | Greentech Sa | Procede d'obtention d'un extrait d'ecorce de bouleau, betula alba, et especes apparentees |
JP2001192338A (ja) * | 2000-01-11 | 2001-07-17 | Pola Chem Ind Inc | ストレスの悪影響からの回復促進剤及びそれを含有してなる皮膚外用剤 |
JP2001200237A (ja) * | 2000-01-20 | 2001-07-24 | Pokka Corp | 紫外線吸収剤及びそれを含有した皮膚外用剤 |
JP2001220344A (ja) * | 2000-02-09 | 2001-08-14 | Ichimaru Pharcos Co Ltd | 植物水蒸気蒸留水含有化粧料組成物 |
JP4726022B2 (ja) * | 2000-03-28 | 2011-07-20 | キッコーマン株式会社 | 抗アレルギー、抗炎症剤並びにこれを含有する医薬組成物、医薬部外品、化粧品、食品及び動物用飼料 |
JP2001348338A (ja) * | 2000-06-06 | 2001-12-18 | Noevir Co Ltd | コラーゲン産生促進剤、及びこれを含有する老化防止用皮膚外用剤 |
US6649178B2 (en) * | 2000-06-13 | 2003-11-18 | Fatemeh Mohammadi | Cosmetic composition for stressed skin under extreme conditions |
JP2002097149A (ja) * | 2000-09-20 | 2002-04-02 | Noevir Co Ltd | 皮膚外用剤 |
AU2001295602A1 (en) * | 2000-10-10 | 2002-04-22 | Bayer Aktiengesellschaft | Regulation of human phospholipase a2-like enzyme |
JP2002193733A (ja) * | 2000-12-25 | 2002-07-10 | Kanebo Ltd | 化粧料 |
DE10107323A1 (de) * | 2001-02-16 | 2002-10-02 | Bernd Gath | Zusammensetzung zur Steigerung von Entgiftungs-Stoffwechselvorgängen |
DE10131188B4 (de) * | 2001-05-03 | 2005-06-16 | Coletica, S.A. | Verfahren zum Testen einer Substanz, die potentiell auf dem Gebiet der Lipolyse wirksam ist, und die hauptsächliche kosmetische Verwendung hiervon |
JP4615796B2 (ja) * | 2001-11-20 | 2011-01-19 | 株式会社ファンケル | 刺激緩和組成物 |
DE10219139A1 (de) * | 2002-04-29 | 2003-11-13 | Sauer Pharma Gmbh & Co Kg | Phytaminpräparat |
JP2004075661A (ja) * | 2002-06-18 | 2004-03-11 | Shiseido Co Ltd | 表皮基底膜ケアを特徴とする皮膚外用剤、皮膚基底膜構造形成促進剤および人工皮膚の製造方法 |
FR2841782B1 (fr) * | 2002-07-08 | 2004-09-17 | Clarins Lab | Composition cosmetique capable de lutter contre le vieillissement cutane |
US20050186172A1 (en) * | 2002-07-08 | 2005-08-25 | Laboratoires Clarins, A Corporation Of France | Cosmetic composition capable of fighting against skin aging |
US20090068299A1 (en) * | 2007-09-07 | 2009-03-12 | Bionovo, Inc. | ESTROGENIC EXTRACTS OF Pueraria lobata Willd. Ohwi of the Leguminosae Family AND USES THEREOF |
GB2483934A (en) * | 2010-09-27 | 2012-03-28 | Gary William Wheatley | Botanical extracts obtained by subcritical water extraction |
-
2002
- 2002-11-19 FR FR0214490A patent/FR2847267B1/fr not_active Expired - Lifetime
-
2003
- 2003-02-12 US US10/365,897 patent/US20040096925A1/en not_active Abandoned
- 2003-02-20 CH CH00269/03A patent/CH694107A5/fr not_active IP Right Cessation
- 2003-02-26 JP JP2003048891A patent/JP2004166684A/ja not_active Withdrawn
- 2003-03-21 KR KR20030017869A patent/KR101172700B1/ko not_active IP Right Cessation
- 2003-05-08 DE DE2003120603 patent/DE10320603A1/de not_active Withdrawn
- 2003-05-08 DE DE10362194.6A patent/DE10362194C5/de not_active Expired - Lifetime
-
2009
- 2009-02-16 JP JP2009032657A patent/JP5425489B2/ja not_active Expired - Fee Related
-
2012
- 2012-07-30 JP JP2012168187A patent/JP2012224637A/ja active Pending
-
2014
- 2014-12-30 US US14/585,256 patent/US20150110907A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CH694107A5 (fr) | 2004-07-15 |
FR2847267A1 (fr) | 2004-05-21 |
KR101172700B1 (ko) | 2012-08-09 |
DE10362194C5 (de) | 2016-10-27 |
US20040096925A1 (en) | 2004-05-20 |
KR20040044076A (ko) | 2004-05-27 |
JP2009108104A (ja) | 2009-05-21 |
JP5425489B2 (ja) | 2014-02-26 |
US20150110907A1 (en) | 2015-04-23 |
DE10362194B4 (de) | 2008-11-13 |
JP2004166684A (ja) | 2004-06-17 |
JP2012224637A (ja) | 2012-11-15 |
DE10320603A1 (de) | 2004-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2847267B1 (fr) | Procede de test de l'activite d'une substance potentiellement active pour inhiber l'activite enzymatique de la phospholipase a2 | |
EE200000522A (et) | Fosfolipaas A2 ensüümi inhibiitor, seda sisaldav farmatseutiline kompositsioon ning meetod fosfolipaasensüümi toime pärssimiseks | |
NO20004219L (no) | Inhibitorer av fosfolipaseenzymer | |
NO20004220L (no) | Inhibitorer av fosfolipaseenzymer | |
FR2833100B1 (fr) | Procede de reconstitution d'une image d'un organe | |
ITMI20011987A0 (it) | Procedimento e sistema basati su computer per l'analisi di misurazione di manufatti | |
ATE325791T1 (de) | Hydroxypipecolate-hydroxamsäure-derivative als mmp inhibitoren | |
DK125696A (da) | Inhibitorer for rotamase enzymaktivitet | |
FR2849636B1 (fr) | Procede de determination d'un etat de freinage | |
AU2002256619A1 (en) | Method for identifying herbicidally active substances | |
FI20000111A0 (fi) | Menetelmä paperinvalmistusprosessin analysoimiseksi ja sähkökemiallinen anturi nesteen analysoimiseksi | |
EP1402276A4 (fr) | Procede pour determiner lorsque des electrodes sont hors d'usage par detection de l'humidite relative | |
DE69838059D1 (de) | Monitor für lösliche chemische Substanzen | |
ATE445837T1 (de) | Heilmittel für nierenkrankheiten und verfahren zum screenen selbiger | |
DK1456404T3 (da) | Fremgangsmåde til at bestemme difibrotids biologiske aktivitet | |
FR2852700B1 (fr) | Procede et installation d'imagerie acousto-optique. | |
FR2843126B1 (fr) | "methode de determination d'une activite enzymatique endoglycosidase" | |
HK1061700A1 (en) | An assay for detecting inhibitors of the enzyme myeloperokidase | |
DE60214316D1 (de) | Chirp-Messverfahren | |
EP1349961A4 (fr) | Procedes de determination des effets biologiques de composes sur l'expression genetique | |
AU2003212405A1 (en) | Method for determining the scale of an observation area | |
FR2872933B1 (fr) | Procede de partage de temps d'un processeur | |
DE10249413B4 (de) | Verfahren zum Erfassen des Beginns eines aktiven Signalabschnitts | |
FR2809118B1 (fr) | Procede pour analyser la lignee phyletique des coquilles saint-jacques | |
FR2824163B1 (fr) | Procede de localisation d'elements d'interet d'un organe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CD | Change of name or company name | ||
PLFP | Fee payment |
Year of fee payment: 14 |
|
PLFP | Fee payment |
Year of fee payment: 15 |
|
PLFP | Fee payment |
Year of fee payment: 16 |
|
PLFP | Fee payment |
Year of fee payment: 18 |
|
PLFP | Fee payment |
Year of fee payment: 19 |
|
PLFP | Fee payment |
Year of fee payment: 20 |